NCT00717392

Brief Summary

Hippotherapy is every program of horseback riding meant to treat people with physiological, mental, social, cognitive or behavioral problems. The purpose of the current research is to evaluate the efficacy of hippotherapy for children with developmental disabilities. The hypothesis is that children with developmental disabilities who are treated with hippotherapy will show better outcomes than children with the same problems who are not treated with hippotherapy.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Sep 2008

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 16, 2008

Completed
1 day until next milestone

First Posted

Study publicly available on registry

July 17, 2008

Completed
2 months until next milestone

Study Start

First participant enrolled

September 1, 2008

Completed
2.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2011

Completed
1.1 years until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2012

Completed
Last Updated

March 1, 2013

Status Verified

February 1, 2013

Enrollment Period

2.7 years

First QC Date

July 16, 2008

Last Update Submit

February 28, 2013

Conditions

Attention Deficit Hyperactivity DisorderAutism Spectrum Disorder

Keywords

ADHDASD

Outcome Measures

Primary Outcomes (1)

  • Improving the parameters of autism

    Repetitive behaviors Eye contact Communication

    Repetitive behaviors

Study Arms (4)

Hippotherapy_ADHD

10 children with ADHD who receive hippotherapy

Hippotherapy_ASD

10 children with ASD who receive hippotherapy

Control_ADHD

10 children with ADHD who DO NOT receive hippotherapy

Control_ASD

10 children with ASD who DO NOT receive hippotherapy

Eligibility Criteria

Age5 Years - 17 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)
Sampling MethodNon-Probability Sample
Study Population

Hippotherapy subjects will be taken from horseback riding farms. Control subjects will be taken from a tertiary care clinic.

You may qualify if:

  • Age: 5-17 years.
  • A diagnosis of ADHD or ASD.

You may not qualify if:

  • None.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Weinberg Child Development Center, Sheba Medical Center, Tel-Hashomer

Ramat Gan, Israel

Location

MeSH Terms

Conditions

Attention Deficit Disorder with HyperactivityAutism Spectrum Disorder

Condition Hierarchy (Ancestors)

Attention Deficit and Disruptive Behavior DisordersNeurodevelopmental DisordersMental DisordersChild Development Disorders, Pervasive

Study Officials

  • Lidia Gabis, MD

    Sheba Medical Center

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER GOV
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Director, The Weinberg Child Development Center

Study Record Dates

First Submitted

July 16, 2008

First Posted

July 17, 2008

Study Start

September 1, 2008

Primary Completion

June 1, 2011

Study Completion

July 1, 2012

Last Updated

March 1, 2013

Record last verified: 2013-02

Locations

IL(1)